The American Cancer Society’s revised prostate cancer screening guidance moves beyond simply advising men to discuss testing with a doctor. It recommends PSA blood tests every two years for men at average risk from ages 50 through 69. Black men and men with a strong family history should begin at 45. Men aged 70 to 74 are advised to weigh screening’s benefits and drawbacks with their doctors; screening should stop at 75, or when someone is not expected to live another 10 years. The guidance also adjusts intervals based on PSA results: a level of 3.0 or higher calls for yearly testing, while 2.5 or lower supports testing every two years. A rising PSA trend matters more than one abnormal reading, and elevated results may prompt consideration of MRI.
The society says evidence now shows PSA screening can reduce the risk of dying from prostate cancer. The disease is common in the United States, and Black men face higher incidence and more than twice the risk of death compared with other men. Screening recommendations remain inconsistent across medical organizations: some leave decisions to patients and doctors, while others recommend screening only for selected age groups or do not recommend it. PSA testing can also lead to false alarms, diagnosis of slow-growing cancers, and treatments that cause lasting urinary, sexual, or bowel problems without extending life. Adoption of formal guideline changes may take years.
Summary generated by AI from the linked article. hn.today is not affiliated with Hacker News or Y Combinator.